John Wiley & Sons, Inc.
As of Oct 22, 2026, John Wiley & Sons is in Stage 3, the topping phase, now in week 4 (since Sep 30, 2026). It closed at $54.08, at its 52-week high and above its 200-day average, which is rising.
John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Ki… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is WLYB early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
WLYB among Publishing4th of 9 by relative strength
All 9 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TDAY | Stage 4 · wk 3 | 94 | +10.2% |
| 2 | LEE | Stage 4 · wk 3 | 88 | −4.7% |
| 3 | WLY | Stage 3 · wk 4 | 86 | +14.0% |
| 4 | WLYB | Stage 3 · wk 4 | 86 | +14.1% |
| 5 | SCHL | Stage 4 · wk 2 | 80 | +10.3% |
| 6 | PSO | Stage 2 · wk 1 | 74 | +15.7% |
| 7 | NYT | Stage 4 · wk 11 | 73 | +12.6% |
| 8 | EDUC | Stage 4 · wk 5 | 33 | −21.5% |
John Wiley & Sons: quick answers
What stage is John Wiley & Sons in?
As of Oct 22, 2026, John Wiley & Sons (WLYB) is in Stage 3, the topping phase. It entered Stage 3 on Sep 30, 2026 and is in week 4. What the four stages mean
Is John Wiley & Sons in an uptrend?
Its uptrend has stalled. John Wiley & Sons is in Stage 3, the topping phase that follows an advance. It trades 27.3% above its 200-day average, which is rising.
How far is John Wiley & Sons from its 52-week high?
John Wiley & Sons closed at $54.08 on Oct 22, 2026, at its 52-week high. Its 52-week low is $28.94.
How has John Wiley & Sons performed over the past year?
As of Oct 22, 2026, John Wiley & Sons is up 49.1% over the past year and up 77.5% so far in 2026.
Which sector and industry is John Wiley & Sons in?
John Wiley & Sons is in the Publishing industry, part of the Communication Services sector.
About this companyCommunication Services· Publishing
John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Kingdom, Germany, and internationally. It operates through Research and Learning segment. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company's Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.